130 related articles for article (PubMed ID: 1794414)
21. Molecular mechanisms of the gastric toxicity of antirheumatic drugs.
Aehringhaus U; Weiler H; Peskar BA; Peskar BM
Arch Toxicol Suppl; 1984; 7():323-7. PubMed ID: 6595998
[TBL] [Abstract][Full Text] [Related]
22. Calcium paradox-evoked release of prostacyclin and immunoreactive leukotriene C4 from rat and guinea-pig hearts. Evidence that endogenous prostaglandins inhibit leukotriene biosynthesis.
Karmazyn M
J Mol Cell Cardiol; 1987 Mar; 19(3):221-30. PubMed ID: 3110422
[TBL] [Abstract][Full Text] [Related]
23. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
[TBL] [Abstract][Full Text] [Related]
24. [Experimental findings on gastric ulcerogenicity and mucosa protection by benzydamine in the rat].
Hell I
Arzneimittelforschung; 1987 May; 37(5A):629-31. PubMed ID: 3619984
[TBL] [Abstract][Full Text] [Related]
25. Age-related reductions in gastric mucosal prostaglandin levels increase susceptibility to aspirin-induced injury in rats.
Lee M; Feldman M
Gastroenterology; 1994 Dec; 107(6):1746-50. PubMed ID: 7958687
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
[TBL] [Abstract][Full Text] [Related]
27. Fatty acid-mediated gastroprotection does not correlate with prostaglandin elevation in rats exposed to various chemical insults.
Mandel KG; Bertram TA; Eichhold MK; Pepple SC; Doyle MJ
Vet Pathol; 1994 Nov; 31(6):679-88. PubMed ID: 7863584
[TBL] [Abstract][Full Text] [Related]
28. Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo.
Jeremy JY; Thompson CS; Mikhailidis DP; Dandona P
Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):195-9. PubMed ID: 2281122
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of PG production by MDL 035, a new non-steroidal non-acidic anti-inflammatory compound, in rat gastric mucosa and inflammatory exudate.
Luzzani F; Colombo G; Schiatti P; Selva D; Glässer A
Pharmacol Res Commun; 1984 Aug; 16(8):755-63. PubMed ID: 6333688
[TBL] [Abstract][Full Text] [Related]
30. Effects of sucralfate on gastric prostaglandin and leukotriene synthesis: relationship to protective actions.
Wallace JL; Morris GP; Beck PL; Williamson TE; Gingras GR
Can J Physiol Pharmacol; 1988 May; 66(5):666-70. PubMed ID: 3416236
[TBL] [Abstract][Full Text] [Related]
31. Etodolac: effect on prostaglandin concentrations in gastric mucosa of rats.
Lee D; Dvornik D
Life Sci; 1985 Mar; 36(12):1157-62. PubMed ID: 3157036
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects of nabumetone with indomethacin on rat gastric mucosal 6-keto-PGF1 alpha production and on bile salt-induced changes in gastric mucosal function.
Melarange R; Rashbrook LC
J Pharm Pharmacol; 1987 Sep; 39(9):717-20. PubMed ID: 2445949
[TBL] [Abstract][Full Text] [Related]
33. Effects of ropivacaine on eicosanoid release from human granulocytes and endothelial cells in vitro.
Martinsson T; Haegerstrand A; Dalsgaard CJ
Inflamm Res; 1997 Oct; 46(10):398-403. PubMed ID: 9372311
[TBL] [Abstract][Full Text] [Related]
34. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins.
Konturek PC; Brzozowski T; Konturek SJ; Taut A; Kwiecien S; Pajdo R; Sliwowski Z; Hahn EG
Digestion; 1998; 59(4):284-97. PubMed ID: 9693198
[TBL] [Abstract][Full Text] [Related]
35. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects.
Anand BS; Romero JJ; Sanduja SK; Lichtenberger LM
Am J Gastroenterol; 1999 Jul; 94(7):1818-22. PubMed ID: 10406241
[TBL] [Abstract][Full Text] [Related]
36. Endogenous prostaglandin I2 regulates the neural emergency system through release of calcitonin gene related peptide.
Arai K; Ohno T; Saeki T; Mizuguchi S; Kamata K; Hayashi I; Saigenji K; Murata T; Narumiya S; Majima M
Gut; 2003 Sep; 52(9):1242-9. PubMed ID: 12912853
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide-releasing aspirin protects gastric mucosa against ethanol damage in rats with functional ablation of sensory nerves.
Konturek PC; Brzozowski T; Kania J; Konturek SJ; Hahn EG
Inflamm Res; 2003 Sep; 52(9):359-65. PubMed ID: 14504662
[TBL] [Abstract][Full Text] [Related]
38. The mechanism of cytoprotective effect of CHINOIN-127.
Kapui Z; Boér K; Hermecz I; Gyíres K
Acta Physiol Hung; 1992; 80(1-4):237-45. PubMed ID: 1345193
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of some non-steroidal anti-inflammatory drugs on the ultrastructural integrity and prostaglandin levels in the rat gastric mucosa: relationship to drug uptake.
Rainsford KD; Fox SA; Osborne DJ
Scand J Gastroenterol Suppl; 1984; 101():55-68. PubMed ID: 6443622
[TBL] [Abstract][Full Text] [Related]
40. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
